All filters
Slidesets
What is the Virological support for reduced drug regimens? | Daniel Kuritzkes, MD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
What is the Pharmacological support for reduce drug regimens? | David Back, PhD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Expanding Integrase Inhibitors in the rest of Europe | Miłosz Parczewski, MD, PhD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Implication of the resent Dolutegravir data | Rebecca Zash, MD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Clinical case: Integrase Inhibitors in Africa | Julia Turner, MD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
Designing e-health interventions for HIV care | Guido van den Berk, MD, PhD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
State of the ART: Integrase Inhibitors (clinical overview) | Mauro Schechter, MD, PhD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
One pill a day?: Integration novel delivery systems into routine care | Terry Blaschke, MD
Presented at:
Global HIV Clinical Forum 2018
Slidesets
What is the Clinical support for reduce drug regimens? | Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2018
Meeting
Global HIV Clinical Forum 2018
Meeting
Canadian HIV Clinical Forum 2018
Meeting
Spanish HIV Clinical Forum 2018
Meeting
Chinese HIV Clinical Forum 2018
Slidesets
Comparison of 5 online free access expert databases to check drug-drug interactions between antiretroviral drugs and co-prescribed medications from a French cohort of HIV-infected outpatients - Le
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Clinical Development of Long-Acting Broadly Neutralizing Monoclonal Antibodies: Lessons Learned Thus Far- Richard Koup, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Viral Dynamics and the Search for an HIV Cure - Stephen Becker, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
The use of DAA’s in pregnancy in HCV infected mothers- David Burger, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Clinical case presentation- David Thomas, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Tenofovir exposure during pregnancy and postpartum in hepatitis B mono-infected women on TDF monotherapy compared to HIV-infected women on TDF-containing antiretroviral therapy- Tim Cressey, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Intracellular 007-TP Concentrations are Associated with Gradients of Adherence to Ledipasvir/Sofosbuvir- Leah Jimmerson
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
A Pharmacometabolomics Approach for Predicting Tenofovir diphosphate (TFV-DP) Concentrations in Dried Blood Spots (DBS)- Mustafa Ibrahim
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Application of Physiologically based pharmacokinetic (PBPK) Modelling to Drug Development Decisions- Joga Gobburu, PhD, MBA
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018